Morgan Stanley Warns Stretched Valuations May Temper Lumentum’s (LITE) 2026 AI Growth
Lumentum Holdings Inc. (NASDAQ:LITE) is one of the hottest large-cap stocks of 2025.
Insider Monkey Blog
Goldman Sachs Initiates Iren (IREN) With Neutral Rating, Cites AI Growth and High Valuation
Iren Limited (NASDAQ:IREN) is one of the hottest large-cap stocks of 2025. On December 18, Goldman Sachs initiated coverage of Iren with a Neutral rating and $39 price target.
Cantor Fitzgerald Urges Long Position on Western Digital (WDC) Amid AI Infrastructure Wave
Western Digital Corporation (NASDAQ:WDC) is one of the hottest large-cap stocks of 2025.
15 Best Stocks Under $25 to Buy Now
Stock futures were marginally lower early December 29, as traders grabbed profits at record index levels and exited prominent technology names and precious metals following an...
8 Best Hydrogen and Fuel Cell Stocks to Buy for 2026
Market watchers and investors that paid attention to policy back in 2020 likely envisaged a future in which hydrogen will be a propellant for the economy as a whole.
10 Best AI Stocks to Buy Under $50
Several analyst firms have expressed their surprise at the reported valuation of the Groq deal, stating that although they are aware of Groq’s specialty in chips for inference...
12 Best NASDAQ Stocks to Buy in 2026
On December 30, Victoria Fernandez, Crossmark Chief Market Strategist, joined 'Closing Bell' on CNBC to discuss investment strategies for the technology sector as we head into...
Is C4 Therapeutics (CCCC) One of the Best Biotech Penny Stocks to Buy According to Analysts?
C4 Therapeutics Inc. (NASDAQ:CCCC) is one of the best biotech penny stocks to buy according to analysts.
Is TSMC (TSM) One of the Best Stocks for the Next Decade?
Earlier on December 7, Bernstein raised the firm’s price target on Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:TSM) to $330 from $290 with an Outperform rating.
H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio’s (CLYM) Budoprutug Across Clinical Tracks
Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C.
Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts.
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda
Invivyd Inc. (NASDAQ:IVVD) is one of the best biotech penny stocks to buy according to analysts.
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs
Orchestra BioMed Holdings Inc. (NASDAQ:OBIO) is one of the best biotech penny stocks to buy according to analysts.
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment
Absci Corporation (NASDAQ:ABSI) is one of the best biotech penny stocks to buy according to analysts.
LifeSci Capital Initiates Prime Medicine (PRME), Highlights One-and-Done Potential in Liver and Lung Diseases
Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts.
Rezolute’s Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing
Rezolute Inc. (NASDAQ:RZLT) is one of the best biotech penny stocks to buy according to analysts.
Fractyl Health’s REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use
Fractyl Health Inc. (NASDAQ:GUTS) is one of the best biotech penny stocks to buy according to analysts.
Black Diamond Therapeutics’ Silevertinib Shows 60% Response Rate in Preliminary Phase 2 Lung Cancer Data
Black Diamond Therapeutics Inc. (NASDAQ:BDTX) is one of the best biotech penny stocks to buy according to analysts.
BNP Paribas Exane Reaffirms Rating on Alphabet (GOOGL) Amid Intersect Power Acquisition
Alphabet Inc. (NASDAQ:GOOGL) is one of the best stocks for the next decade.
Is Nvidia (NVDA) One of the Best Stocks for the Next Decade?
Nvidia Corporation (NASDAQ:NVDA) is one of the best stocks for the next decade.
Micron (MU) Positioned for Growth as AI-Driven Memory Demand Triggers Major Analyst Upgrades
Earlier on December 18, Lynx Equity raised the price target on Micron Technology to $325 from $180, as the firm maintains a constructive long-term outlook as the memory cycle ...
Lam Research (LRCX) Leads Etch Market as AI-Driven Memory Supercycle Fuels Robust WFE Spending Outlook Through 2026
Lam Research Corporation (NASDAQ:LRCX) is one of the best stocks for the next decade.
AbbVie (ABBV) Maintains Immunology Dominance as Analysts Downplay Competitive Threat From J&J’s Tremfya to Skyrizi Market Share
AbbVie Inc. (NYSE:ABBV) is one of the best stocks for the next decade.
ASML (ASML) Positioned for Growth as Citi Identifies AI Demand as Primary Catalyst for 2026 Semiconductor Equipment Outlook
ASML Holding (NASDAQ:ASML) is one of the best stocks for the next decade.
Quanta Services (PWR) Set for 2026 Recovery as Bernstein Forecasts Policy-Driven Reversal of Cyclical Downturn
Quanta Services Inc. (NYSE:PWR) is one of the best stocks for the next decade.
Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua...
Alibaba Group Holding (BABA) Limited Reported a Good Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua...
New Fortress (NFE) Falls 5% on Credit Concerns
New Fortress dropped for a second day on Tuesday, shedding 5.17 percent to close at $1.10 apiece amid lingering concerns over its financial standing, further dampened by a credit...
Here’s Why Genmab A/S (GMAB) Rose in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua...
ASP Isotopes (ISP) Loses 5% as Exec Unloads Stake
ASP Isotopes extended its losing streak to a third day on Tuesday, shedding 5.08 percent to close at $5.42 apiece as investors mirrored a key executive’s disposition of a significant...
HIVE Digital (HIVE) Drops 5% – Here’s Why
HIVE Digital extended its losing streak to a third day on Tuesday, shedding 5.17 percent to close at $2.57 apiece as investors took profits amid the lack of fresh catalysts to...
Rivian Automotive (RIVN) Loses 5% as CEO Unloads Stake
Rivian Automotive extended its losing streak to a sixth straight session on Tuesday, shedding 5.22 percent to close at $19.59 apiece as investors mirrored its chief executive’...
Strive Asset (ASST) Loses 5.3% on Lack of Devt
Strive Asset dropped for a third day on Tuesday, losing 5.35 percent to close at $0.7320 apiece as investors unloaded positions anew amid the lack of fresh leads to boost buying...
Array Technologies (ARRY) Drops 5.6% Ahead of Tax Credit Deadline
Array Technologies dropped for a second day on Tuesday, shedding 5.62 percent to close at $9.40 apiece as investors continued to take profits after the stock retested the $10 ...
Energy Fuels (UUUU) Loses 5.7% on Profit-Taking
Energy Fuels dropped its share prices by 5.71 percent on Tuesday to close at $14.21 apiece as investors took early profits following the previous day’s jump, supported by its...
SES AI (SES) Sheds 6% on Profit-Taking
Last Monday, SES AI Corporation (NYSE:SES) presented at the 5th annual Battery World, where it unveiled its latest version of Molecular Universe (MU-1.5) and details on its new...
US Antimony (UAMY) Loses 7.66% on Profit-Taking
US Antimony extended its winning streak to a third straight day on Tuesday, shedding 7.66 percent to close at $5.18 apiece mainly due to continued profit-taking from last week...
Here’s Why Novo Nordisk (NVO) Traded Down in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua...
Eightco Holdings (ORBS) Tumbles 8% on Profit-Taking
Eightco Holdings fell by 8.17 percent on Tuesday to close at $1.6850 apiece as investors resorted to profit-taking following the previous day’s surge, triggered by a $125 million...
Baird Chautauqua International and Global Growth Fund’s Q3 2025 Investor Letter
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua...
Excellent Results Boosted GE Aerospace (GE) in Q3
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Here’s What Lifted Thermo Fisher Scientific (TMO) in Q3
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Bristol Gate US Equity Strategy Exited Its Stake in Marsh & McLennan (MMC)
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
What Makes Amphenol (APH) an Attractive Investment?
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Intuit (INTU) Slipped as the Outlook and Guidance Fell Short of Expectations
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Do You Believe in the Growth Potential of Accenture (ACN)?
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Carrier Global Corporation (CARR) Fell in Q3 Despite Good Results
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Bristol Gate US Equity Strategy: NVDA’s Demand Today is Broadcom’s (AVGO) Opportunity Tomorrow
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Bristol Gate Capital Partners US Equity Strategy’s Q3 2025 Investor Letter
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”.
Hedge Fund Resource Center
